DK517588A - L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse - Google Patents

L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse

Info

Publication number
DK517588A
DK517588A DK517588A DK517588A DK517588A DK 517588 A DK517588 A DK 517588A DK 517588 A DK517588 A DK 517588A DK 517588 A DK517588 A DK 517588A DK 517588 A DK517588 A DK 517588A
Authority
DK
Denmark
Prior art keywords
optionally substituted
denotes
preparation
additional salts
acid additional
Prior art date
Application number
DK517588A
Other languages
Danish (da)
English (en)
Other versions
DK517588D0 (da
Inventor
Yoshimi Tsuchiya
Masahiro Hayashi
Hiroshi Takehana
Akihiro Hisaka
Yoshio Sawasaki
Masaki Ihara
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of DK517588D0 publication Critical patent/DK517588D0/da
Publication of DK517588A publication Critical patent/DK517588A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK517588A 1987-09-18 1988-09-16 L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse DK517588A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP23429987 1987-09-18
JP3126088 1988-02-13

Publications (2)

Publication Number Publication Date
DK517588D0 DK517588D0 (da) 1988-09-16
DK517588A true DK517588A (da) 1989-03-19

Family

ID=26369718

Family Applications (1)

Application Number Title Priority Date Filing Date
DK517588A DK517588A (da) 1987-09-18 1988-09-16 L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse

Country Status (12)

Country Link
US (1) US4966915A (enExample)
EP (1) EP0309827B1 (enExample)
JP (1) JPH02138A (enExample)
KR (1) KR890005031A (enExample)
CN (1) CN1032785A (enExample)
AT (1) ATE71083T1 (enExample)
AU (1) AU2234088A (enExample)
CA (1) CA1316180C (enExample)
DE (1) DE3867403D1 (enExample)
DK (1) DK517588A (enExample)
IL (1) IL87765A0 (enExample)
PT (1) PT88526B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005526728A (ja) * 2002-02-15 2005-09-08 ダーファーマ,インコーポレイテッド ドーパミンd1受容体アゴニストのモノエステルプロドラッグおよび非対称置換ジエステルプロドラッグ
AU2003293423A1 (en) 2002-12-06 2004-06-30 Xenoport, Inc. Carbidopa prodrugs and uses thereof
US7471862B2 (en) 2002-12-19 2008-12-30 Corning Cable Systems, Llc Dry fiber optic cables and assemblies
US6970629B2 (en) 2002-12-19 2005-11-29 Corning Cable Systems Llc Optical tube assembly having a dry insert and methods of making the same
US20090190890A1 (en) 2002-12-19 2009-07-30 Freeland Riley S Fiber optic cable having a dry insert and methods of making the same
IL154318A (en) 2003-02-06 2010-05-31 Sarah Herzog Memorial Hospital Pharmaceutical compositions for the treatment of movement disorders
US7342131B2 (en) 2004-06-04 2008-03-11 Xenoport, Inc. Levodopa prodrugs, and compositions and uses thereof
US7323585B2 (en) * 2004-06-04 2008-01-29 Xenoport, Inc. Levodopa prodrugs, and compositions and uses thereof
EP1959948B1 (en) * 2005-12-05 2012-07-18 XenoPort, Inc. Levodopa prodrug mesylate, compositions thereof, and uses thereof
US7829592B2 (en) 2006-12-21 2010-11-09 Xenoport, Inc. Catechol protected levodopa diester prodrugs, compositions, and methods of use
TW200843732A (en) * 2006-12-21 2008-11-16 Xenoport Inc Levodopa dimethyl-substituted diester prodrugs, compositions, and methods of use
WO2010047775A2 (en) * 2008-10-20 2010-04-29 Xenoport, Inc. Methods of synthesizing a levodopa ester prodrug
US8399513B2 (en) * 2008-10-20 2013-03-19 Xenoport, Inc. Levodopa prodrug mesylate hydrate
KR101025612B1 (ko) * 2008-11-10 2011-03-30 한국해양연구원 신규 화합물인 Ramalin 및 그 용도
WO2011056240A2 (en) 2009-11-09 2011-05-12 Xenoport, Inc. Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
KR101868326B1 (ko) 2010-03-04 2018-06-19 오리온 코포레이션 파킨슨병의 치료를 위한 레보도파, 카르비도파 및 엔타카폰의 용도
CN103694127B (zh) * 2013-12-30 2015-04-01 上海交通大学 链霉菌属菌种所产的化合物及该化合物的制备方法和应用
MX393568B (es) 2014-10-21 2025-03-24 Abbvie Inc Profarmacos de carbidopa y l-dopa y metodos de uso
AU2016258179B2 (en) 2015-05-06 2021-07-01 Synagile Corporation Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use
WO2019097120A1 (en) 2017-11-16 2019-05-23 Orion Corporation New use and pharmaceutical dosage forms
UY38473A (es) 2018-11-15 2020-06-30 Abbvie Inc Formulaciones farmacéuticas para una administración subcutánea
US20220213128A1 (en) * 2021-01-03 2022-07-07 RockGen Therapeutics LLC L-Dopa Enhanced with a Neuroprotective Agent as a Therapy for Parkinson's Disease
WO2023064783A1 (en) * 2021-10-11 2023-04-20 The Johns Hopkins University Dopa and caffiec acid analogs as novel gcpii inhibitors
WO2025075499A1 (en) 2023-10-02 2025-04-10 Universiteit Van Amsterdam Reducing dopamine feed-back inhibition in dopaminergic cells by tadalafil.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US393923A (en) * 1888-12-04 Samuel preston
US2868818A (en) * 1953-12-15 1959-01-13 Merck & Co Inc Alpha methyl phenylalanines
US3725470A (en) * 1969-05-14 1973-04-03 Hoffmann La Roche Amino acid derivatives
CH562199A5 (enExample) * 1970-10-30 1975-05-30 Hoffmann La Roche
BE793426A (fr) * 1971-12-28 1973-06-28 Lannacher Heilmittel G M B H Derives de phenylalanine
US3983138A (en) * 1973-09-25 1976-09-28 Merck & Co., Inc. Amino acid esters
US3939253A (en) * 1973-11-02 1976-02-17 Interx Research Corporation Novel, transient pro-drug forms of l-dopa useful in the treatment of parkinson's disease
US3891696A (en) * 1973-11-02 1975-06-24 Interx Research Corp Novel, transient pro-drug forms of l-dopa
US4401676A (en) * 1977-06-01 1983-08-30 Merck & Co., Inc. Novel α-amino acids
US4311706A (en) * 1980-01-22 1982-01-19 Interx Research Corporation Novel dopa/dopamine prodrugs

Also Published As

Publication number Publication date
DK517588D0 (da) 1988-09-16
DE3867403D1 (de) 1992-02-13
PT88526B (pt) 1992-11-30
JPH0541626B2 (enExample) 1993-06-24
JPH02138A (ja) 1990-01-05
PT88526A (pt) 1988-10-01
CN1032785A (zh) 1989-05-10
US4966915A (en) 1990-10-30
ATE71083T1 (de) 1992-01-15
KR890005031A (ko) 1989-05-11
EP0309827A1 (en) 1989-04-05
CA1316180C (en) 1993-04-13
AU2234088A (en) 1989-03-23
EP0309827B1 (en) 1992-01-02
IL87765A0 (en) 1989-02-28

Similar Documents

Publication Publication Date Title
DK517588D0 (da) L-dopa-derivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
DE3762618D1 (de) Amidderivate.
DK616388D0 (da) Quinolincarboxylsyre-derivater og fysiologisk acceptable salte deraf med antibakteriel virkning
FR2800735B1 (fr) Nouvelles aralkyle-1,2-diamines possedant une activite calcimimetique et leur mode de preparation
ATE184483T1 (de) Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ATE92489T1 (de) Imid-derivate, ihre herstellung und verwendung.
DK147588D0 (da) Benzoxazinderivat samt fremgangsmaade til fremstilling deraf
AU632877B2 (en) Oxetane derivatives, their preparation and their use as anti-fungal or fungicidal agents
DE3167155D1 (en) Aminopropanol derivatives, process for their preparation and their use as fungicides
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
DK121789A (da) 4,5,6,7-tetrahydroisothiazole oe4,5-caapyridinderivater
DK96086D0 (da) 8-thiotetrahydroquinolinderivater, deres fremstilling og anvendelsesom laegemidler
NO881734D0 (no) Tiadiazolguanidiner og fremgangsmaate for deres fremstilling.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DK0420464T3 (da) 3-isoxazolonderivater, deres fremstilling af deres terapeutiske anvendelser
ATE135689T1 (de) 1,2,3,6-tetrahydronpyridinderivate

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment